Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Nov;28(5):689–690. doi: 10.1128/aac.28.5.689

In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.

S Alvarez, M Jones, S L Berk
PMCID: PMC176358  PMID: 3853963

Abstract

We tested 148 strains of clinical isolates of methicillin-resistant Staphylococcus aureus against fosfomycin alone and in combination with methicillin, cefamandole, gentamicin, trimethoprim, and vancomycin. Fosfomycin inhibited 90% of the 148 methicillin-resistant S. aureus strains at a concentration of 4 micrograms/ml. Synergism was observed in 97 strains (66%) with fosfomycin-cefamandole and in 69 strains (46%) with fosfomycin-methicillin. The combinations of fosfomycin with vancomycin, gentamicin, and trimethoprim were indifferent in most strains.

Full text

PDF
689

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews J. M., Baquero F., Beltran J. M., Canton E., Crokaert F., Gobernado M., Gomez-Ius R., Loza E., Navarro M., Olay T. International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother. 1983 Oct;12(4):357–361. doi: 10.1093/jac/12.4.357. [DOI] [PubMed] [Google Scholar]
  2. Craven D. E., Kollisch N. R., Hsieh C. R., Connolly M. G., Jr, McCabe W. R. Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis. 1983 Jan;147(1):137–143. doi: 10.1093/infdis/147.1.137. [DOI] [PubMed] [Google Scholar]
  3. Forsgren A., Walder M. Antimicrobial activity of fosfomycin in vitro. J Antimicrob Chemother. 1983 May;11(5):467–471. doi: 10.1093/jac/11.5.467. [DOI] [PubMed] [Google Scholar]
  4. Guenthner S. H., Wenzel R. P. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1984 Aug;26(2):268–269. doi: 10.1128/aac.26.2.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kahan F. M., Kahan J. S., Cassidy P. J., Kropp H. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci. 1974 May 10;235(0):364–386. doi: 10.1111/j.1749-6632.1974.tb43277.x. [DOI] [PubMed] [Google Scholar]
  6. Peacock J. E., Jr, Moorman D. R., Wenzel R. P., Mandell G. L. Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. J Infect Dis. 1981 Dec;144(6):575–582. doi: 10.1093/infdis/144.6.575. [DOI] [PubMed] [Google Scholar]
  7. Peters G., Schumacher-Perdreau F., Pulverer G. Vergleich der Staphylokokken- und Mikrokokken-Wirksamkeit von Fosfomycin, Oxacillin und Penicillin G. Dtsch Med Wochenschr. 1980 Oct 31;105(44):1541–1543. doi: 10.1055/s-2008-1070908. [DOI] [PubMed] [Google Scholar]
  8. Rodríguez A., Gallego A., Olay T., Mata J. M. Bacteriological evaluation of fosfomycin in clinical studies. Chemotherapy. 1977;23 (Suppl 1):247–258. doi: 10.1159/000222055. [DOI] [PubMed] [Google Scholar]
  9. Sicilia T., Estévez E., Rodríguez A. Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis. Chemotherapy. 1981;27(6):405–413. doi: 10.1159/000238009. [DOI] [PubMed] [Google Scholar]
  10. Sorrell T. C., Packham D. R., Shanker S., Foldes M., Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):344–350. doi: 10.7326/0003-4819-97-3-344. [DOI] [PubMed] [Google Scholar]
  11. Thompson R. L., Cabezudo I., Wenzel R. P. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):309–317. doi: 10.7326/0003-4819-97-3-309. [DOI] [PubMed] [Google Scholar]
  12. Thompson R. L., Wenzel R. P. International recognition of methicillin-resistant strains of Staphylococcus aureus. Ann Intern Med. 1982 Dec;97(6):925–926. doi: 10.7326/0003-4819-97-6-925. [DOI] [PubMed] [Google Scholar]
  13. Thornsberry C., McDougal L. K. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol. 1983 Nov;18(5):1084–1091. doi: 10.1128/jcm.18.5.1084-1091.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES